The main research activity of the Neurocognition working group focuses on clinical applications of the combination of imaging (MRI, EEG) and behavioral methods for research, diagnostics and non-pharmacological interventions aimed at cognitive functions, especially in neuropsychiatric disorders (primarily schizophrenic diseases). Thanks to this connection, our research can contribute to the detection, prevention and remediation of cognitive deficit as a risk factor for functional disability.

We also participate in neuropsychological examinations within the multimodal prospective database of first episodes of psychotic illness (ESO) and we also cooperate with the NIMH day care center for psychotic illnesses, where we conduct computerized cognitive training and social skills training as part of the PharmaBrain study.